in

Abemaciclib Ups Overall Survival in High-Risk Breast Cancer

Source link : https://newshealth.biz/health-news/abemaciclib-ups-overall-survival-in-high-risk-breast-cancer/

Adding the CDK4/6 inhibitor abemaciclib to endocrine therapy significantly improves overall survival in node-positive, high-risk early breast cancer, in the extended follow-up of a landmark trial. Medscape Medical News Source link : https://www.medscape.com/viewarticle/abemaciclib-ups-overall-survival-high-risk-breast-cancer-2025a1000san?src=rss Author : Publish date : 2025-10-18 14:25:00 Copyright for syndicated content belongs to the linked Source.

The post Abemaciclib Ups Overall Survival in High-Risk Breast Cancer first appeared on News Health.

—-

Author : News Health

Publish date : 2025-10-18 14:25:00

Copyright for syndicated content belongs to the linked Source.

—-

12345678

Proteas’ Discipline Shuts Down Sri Lanka’s Batting – Innings Highlights

Work wherever, on something, with this cross-platform workplace suite